The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Michele T. Yip-Schneider

Department of Surgery

Indiana University School of Medicine

Indianapolis

USA

[email]@iupui.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Surgery, Indiana University School of Medicine, Indianapolis, USA. 2001 - 2008
  • Department of Medicine, Department of Biochemistry and Walther Oncology Center, Indiana University School of Medicine, Indianapolis 46202, USA. 2000

References

  1. Effect of celecoxib and the novel anti-cancer agent, dimethylamino-parthenolide, in a developmental model of pancreatic cancer. Yip-Schneider, M.T., Wu, H., Njoku, V., Ralstin, M., Holcomb, B., Crooks, P.A., Neelakantan, S., Sweeney, C.J., Schmidt, C.M. Pancreas (2008) [Pubmed]
  2. Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo. Yip-Schneider, M.T., Wu, H., Ralstin, M., Yiannoutsos, C., Crooks, P.A., Neelakantan, S., Noble, S., Nakshatri, H., Sweeney, C.J., Schmidt, C.M. Mol. Cancer Ther. (2007) [Pubmed]
  3. Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells. Yip-Schneider, M.T., Nakshatri, H., Sweeney, C.J., Marshall, M.S., Wiebke, E.A., Schmidt, C.M. Mol. Cancer Ther. (2005) [Pubmed]
  4. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac. Yip-Schneider, M.T., Schmidt, C.M. Pancreas (2003) [Pubmed]
  5. Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2. Yip-Schneider, M.T., Lin, A., Marshall, M.S. Biochem. Biophys. Res. Commun. (2001) [Pubmed]
  6. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Yip-Schneider, M.T., Barnard, D.S., Billings, S.D., Cheng, L., Heilman, D.K., Lin, A., Marshall, S.J., Crowell, P.L., Marshall, M.S., Sweeney, C.J. Carcinogenesis (2000) [Pubmed]
 
WikiGenes - Universities